HLB is becoming a global pharmaceutical company that is developing new drugs for cancers, including the new anticancer drug substance, ‘Rivoceranib’.
Best-in-class targeted cancer therapy
HLB, which has long invested in the bio business to realize its dream
of ‘life-extension & high quality of life’, is now leaving the runway and
taking off in earnest to become a global pharmaceutical company.
Composite Material Division
Lifeboat & Special Ship & Engine
HLB’s Shipping Division is specialized in manufacturing small
ships and special ships. HLB has built 7,000 vessels for over
40 years since 1975 with its accumulated technology and know-how.